Frequently Asked Questions

Do my transgenic animals need to be reviewed by the IBC?

It depends, the guidance document from the Office of Biotechnology Activities regarding FAQ's for Research Subject to the NIH Guidelines is extremely helpful in this determination.  The document can be found here.

What is the purpose of the EHS Risk Assessment Document?
The EHS Risk Assessment Document helps the Principal Investigator convey potential hazards and risks associated with a proposed research project.  This allows EHS staff and the IBC to evaluate the associated risks involved in order to mitigate any potential occupational exposures.

How long does it take to get a protocol approved by the IBC?
This depends. The two most important aspects to protocol submission are ensuring they are submitted by the 1st of each month in order for the document to be reviewed within that month and to ensure an EHS Risk Assessment Document has been satisfactory completed.  The IBC Administrator can help in this process.

Why is my protocol going to the IBC if it's exempt from the NIH Guidelines?
The IBC does not review protocols that are exempt or that do not qualify as described in the NIH Guidelines with regards to recombinant DNA. We will review your protocol if it involves etiological agents, select agent or toxins.  If you feel your protocol does not require IBC approval, please specify this and most importantly, the specific reason as to why.

I'm doing only bench-top research, how do I submit to the IBC?
Completing an EHS Risk Assessment Document and submitting this to ehs@kumc.edu will ensure your research is properly reviewed.

Last modified: Aug 26, 2015